TITAN PHARMACEUTICALS INC (TTNP) Stock News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Mentions: LIXT AKTX SNOA NDRA ...

US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted'

U.S. stock futures rose on Monday following Friday's advances. Futures of major benchmark indices were higher in premarket.

Mentions: QQQ SONY SPY NVDA ...

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Titan Pharmaceuticals (NASDAQ:TTNP) just reported results for the second quarte...

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024

Titan Pharmaceuticals just reported results for the second quarter of 2024.

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023

Titan Pharmaceuticals just reported results for the fourth quarter of 2023.

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders

Mentions: ITI FRZA

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iteris, Inc. (Nasdaq - ITI), Forza X1, Inc. (Nasdaq - FRZA), Titan Pharmaceuticals, Inc. (Nasdaq - TTNP), Gatos Silver, Inc. (NYSE - GATO)

Mentions: GATO ITI FRZA VEEE ...

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024

Titan Pharmaceuticals just reported results for the first quarter of 2024.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders

Mentions: CFB SDIG

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders

Mentions: BALY K

Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders

/PRNewswire/ -- Ademi LLP is investigating Titan (NASDAQ: TTNP) for possible breaches of fiduciary duty and other violations of law in its transaction with KE...

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and...

Titan pharmaceuticals notified of full compliance by NASDAQ (NASDAQ:TTNP)

Titan Pharmaceuticals, Inc. regains compliance with Nasdaq's bid price requirement, ensuring continued listing on The Nasdaq Capital Market.

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that...